Companies /Healthcare

AMGEN Inc

NASDAQ: AMGN Drug Manufacturers - General
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 11:01pm ET

AMGN Coverage

Page 14
8:40am ET
Health and Healthcare

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in most…

Chris Lange
10:00am ET
Health and Healthcare

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in most…

Chris Lange
4:20pm ET
Health and Healthcare

Why Amgen Failed to Impress in Q3

When Amgen released its third-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.66 in earnings per share (EPS) and $5.7 billion in revenue. That compared…

Chris Lange
12:40pm ET
Health and Healthcare

Can Amgen Earnings Keep Up With Biogen?

Amgen is set to report its most recent quarterly results after the closing bell on Tuesday. Wall Street expectations are muted.

Chris Lange
10:00am ET
Health and Healthcare

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in most…

Chris Lange